U.S. Stock News

Innodata shares dropped about 5% today, but the earnings story that hit the tape looks very different from the price chart. You are looking at a stock that has pulled back over the past quarter while the business reported a Q2 revenue figure of US$92.1m and delivered earnings per share above forty cents. The emotional shock is not in the headline numbers. It sits in a market that has been paying a premium P/E for an artificial intelligence data and evaluation story and now has to digest a...

Ridgepost Capital stock slipped into this earnings print with a modestly positive short term run, then popped another 2.3% to close at US$8.99 after the release. That move reflects relief more than euphoria. The headline this quarter is margin pressure. Quarterly earnings per share landed below the prior two quarters even as fee related earnings, the management fee engine of this asset manager, came in solid and largely recurring. For investors the tension is clear. Ridgepost Capital is...

Zymeworks stock inched up 1.8% to US$23.54 into the close, a calm move for a biotech that just posted another hefty quarterly loss. The headline is simple. Revenue stayed modest at US$4.59 million while net loss widened to about US$45 million. The short term story is about cash burn and a thin top line. The longer term story is very different. Forecasts in available analyst reports point to a path to profitability, yet the stock already trades on a rich P/S multiple. That tension between...

Old Second Bancorp stock slipped 1.3% to US$25.44 in regular trading, even though the bank just posted one of its cleanest profitability prints in recent quarters. Net interest margin reached 5.23% and quarterly net income came in at US$28.2m, solid numbers for a regional lender. The short term read looks cautious on the screen. Over a longer horizon, investors weighing a trailing twelve month earnings base of US$92.4m against the current valuation will focus on whether this kind of margin...

Aspen Aerogels just saw its stock drop 9.3% to US$6.25, even though the headline from Q2 is not about collapse; it is about a harsh but narrowing loss profile. Revenue came in at US$49.8m and the company still reported a sizeable net loss of US$23.3m, yet adjusted EBITDA improved compared with Q1. The sentiment shock today sits in that clash. Investors who had warmed to the stock after strong recent returns are suddenly refocusing on the scale of ongoing losses and cash burn. The rest of the...

The RealReal stock gave back 3.7% the day after earnings, even though the quarter put some of the resale bear case under pressure. Coming into the print the shares had climbed almost 20% over the past three months as investors leaned into the luxury consignment recovery story. The headline from Q2 is clear: Gross merchandise value and revenue both set new highs, while adjusted EBITDA margin reached 7% and management lifted full year guidance. Is RealReal’s rich P/S multiple a sign the market...

Smith Douglas Homes came into this earnings print with a stock that has drifted down over the past month and it slipped another 1.4% to about US$13.86 after the release. That mild pullback feels small given the size of the profit squeeze in the quarter. Revenue was US$273.0m, while net income excluding special items was only US$0.2m and earnings per share were roughly US$0.03. The thesis on Smith Douglas Homes has often centered on efficient, land light growth. This quarter directs investor...

BlackSky Technology stock jumped about 5% today to US$29.16, even though the company is still reporting quarterly losses. The market latched onto one thing: Q2 revenue reached US$33.3m while adjusted EBITDA turned positive at US$4.7m, a clear swing for a space data and satellite operator that has been burning cash in prior periods. That short term pop sits on top of a 90 day share price decline of roughly 26%. The real question now is whether this early profitability signal from BlackSky’s...

Cytokinetics walked into this earnings print with a strong growth reputation and a stock that had already cooled, down over the past month, and the market just pushed it lower again. Shares fell about 6% today, even as the headline story was clear early traction for its new cardiomyopathy drug MYQORZO and rising product revenue. The gap is simple. The commercial ramp is starting to show up in the top line, yet the income statement still reflects heavy investment. Cytokinetics posted Q2...

CleanSpark stock came into the day already soft after a weaker three month stretch, then slipped another 3.5% to close near US$12.30. The instinctive read is that investors are reacting to another loss making quarter. The real headline is more complicated. The quarter still carried a US$240 million net loss, yet CleanSpark used the earnings release to recast itself around a 20 year triple net lease on its Sandersville campus. Management says this supports roughly US$6.6 billion in contracted...

Helmerich & Payne stock barely budged after earnings, with the share price up just 0.1% around US$37, even as the quarter flipped from losses to a profit on paper. The headline was simple and sharp for a contract driller. Revenue came in a little above US$1.0b and adjusted earnings power showed through in the rigs. The company delivered US$236m of adjusted earnings before interest, tax, depreciation and amortisation, which is the key profit yardstick investors watch in this capital heavy...

Universal Technical Institute stock closed up 3.9% at US$28.95, even though the quarterly headline is a squeeze, not a surge. Q3 net income came in at US$2.3 million on US$218.9 million of revenue, a far thinner profit pool than investors in this high multiple education stock might hope for. The short term tape looks better than the story. Over the last month the share price is down about 41%, which tells you how fragile confidence was coming into this print. Like the Universal Technical...

Matthews International stock just dropped 14% to US$23.70, and that sharp move reflects how hard today's earnings hit short term sentiment. The company reported a Q3 loss of US$23.7m, or US$0.75 per share, with revenue at US$246.0m. For a stock that already carried questions over profitability and balance sheet flexibility, this quarter lands as a clear margin and earnings squeeze rather than a one off blip. The following sections focus on how that pressure plays through cash generation, debt...

Xponential Fitness just saw its stock drop 21% in a single session, yet the earnings story is less about a sudden collapse and more about a grinding margin squeeze that finally hit investor nerves. The company delivered Q2 revenue of US$66.0m with adjusted EBITDA of US$21.9m and a slimmer 33% margin. At the same time, guidance for full year revenue of US$250m to US$260m and adjusted EBITDA of US$91m to US$97m reset expectations for how profitable this franchise model can be in the near...

Lyft went into this print with a stock that had already been grinding higher, and then the market added another jolt. Shares closed up 7.1% at US$17.46 after the Q2 numbers hit, as investors reacted to a ride hailing business that is throwing off profits rather than just rides. The headline is earnings power. Basic earnings per share reached US$0.13 in Q2 on revenue of US$1.84b, and the trailing P/E multiple now sits near 2x. The gap between that low multiple and the recent price move is what...

Five9 came into this print with the stock already climbing over the past quarter, yet today's nearly 20% jump to about US$34 shows how wide the gap was between caution and what the contact center software company actually delivered. The headline is simple: revenue reached about US$312 million in Q2 and management singled out artificial intelligence driven customer experience as the star, with AI revenue growing far faster than the rest of the business. For you as an investor, the message is...

Brilliant Earth Group shares jumped about 6% to US$1.28 after earnings, a sharp move for a stock that has been under pressure over the past quarter. The market is reacting to a quarter that put profits back on the scoreboard, with Q2 basic earnings per share just above break even and adjusted EBITDA margins near 5%. That is a clear break from recent losses. The bigger question for you is whether this is a short squeeze on relief or the start of a longer reset. Revenue of US$115.1m and...

Planet Fitness stock fell 2.3% today and is roughly flat over the past month, even though the latest quarter showed what many gym operators would recognise as a tougher outcome. Revenue reached US$365 million while adjusted EBITDA margin slipped to 41.8% as higher advertising and equipment costs weighed on profits. For short term traders, this margin squeeze is the headline. For long term investors, the bigger question is whether a franchise heavy, asset light model with an 18.3% trailing net...

Alector shares closed down about 3% at US$1.78, which is a muted move for a biotech stock digesting fresh quarterly numbers. The headline is not the share price. It is the pressure from continuing losses sitting on top of a fragile balance sheet, with negative shareholders’ equity already flagged as a major risk. Q2 2026 again showed meaningful net losses, with net income from ongoing operations in the red and basic earnings per share still negative. For a company with modest revenue and a...

StandardAero stock slipped about 2.7% to US$29.19 after earnings, even though the quarter delivered the kind of margin story investors usually applaud. The company posted roughly US$1.6b in Q2 revenue and a record adjusted earnings before interest, tax, depreciation and amortization margin of 14.4%, which points to firmer profitability in a capacity constrained maintenance, repair and overhaul market. Coming into the print, StandardAero had already climbed over the past three months, so...

Teleflex stock slipped about 3% to US$134.91 today, even as the headline numbers landed on the right side of expectations. The medical technology company delivered Q2 adjusted earnings per share of US$1.76 with revenue of US$570.3m and raised its full year adjusted EPS outlook. The near term reaction reflects concern about softer growth guidance and margin pressure. The longer term picture now hinges on whether Teleflex can turn this transition year of divestitures, integration work and...

ConocoPhillips stock barely budged after earnings, up just 0.7% to about US$118, even though the company put up a muscular quarter on the core metrics that matter in oil and gas. Adjusted earnings per share landed at roughly US$3.23 and total revenue came in near US$19.4b. For a stock that has slipped over the past week but is still ahead over the past month, the muted move signals investors are weighing something bigger than a single quarter. The real story now stretches over years, not...

X4 Pharmaceuticals rose 11% to US$4.63 after its latest quarterly report, a sharp move for a small biotech that still reports losses. The stock now sits on a strong one month and three month gain, which indicates traders reacted positively to the headline figures. The earnings story that moved the price is straightforward. Product revenue in Q2 was US$8.8 million and the company reported a net loss of US$16.2 million. For a drug developer with a Phase III asset, the key debate now is how that...

Western Digital walked into this earnings season with a reputation as a high growth, AI leveraged storage leader trading on a modest 16.1x trailing P/E. Yet the stock dropped about 4% today and is down around 21% over the past month, even as the latest quarter delivered US$3.7b in revenue and very high net profit margins on a trailing basis. The gap between that sharp share price pullback and the strength of the reported profitability is now the core question for investors. The full...